|
US2019262335A1
|
|
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
US2017319575A1
|
|
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
US9737530B1
|
|
Process of making stable abuse-deterrent oral formulations
|
|
US2015004244A1
|
|
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
US2014105987A1
|
|
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
|
US2011052506A1
|
|
Stable Aerosol Topical Foams Comprising a Hypochlorite Salt
|
|
US2011212035A1
|
|
Emollient foams for treatment of dermatoses
|
|
WO2010093523A2
|
|
Foamable microemulsion compositions for topical administration
|
|
WO2010093382A1
|
|
Foamable benzoyl peroxide compositions for topical administration
|
|
US2009018203A1
|
|
Modified release compositions of milnacipran
|
|
EP2120945A1
|
|
Antihistamine combination
|
|
US2008248135A1
|
|
Combination Therapy for Otitis with Antiseptic and pH Adjustment
|
|
WO2007117581A2
|
|
Stabilized transdermal bupropion preparations
|
|
WO2007056439A1
|
|
Salts of methylene blue and its derivatives
|
|
US2007232695A1
|
|
Gelled Periodontal Anesthetic Preparation
|
|
WO2007022090A2
|
|
Topical delivery with a carrier fluid
|
|
EP1907022A2
|
|
Compositions for topical enzymatic debridement
|
|
US2007036843A1
|
|
Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
|
|
AU2005319367A1
|
|
Pharmaceutical compositions for sleep disorders
|
|
US2006024366A1
|
|
Modified release compositions of milnacipran
|
